ストックスクリーナーアプリを入手
1.52
0.00%
0.00
前日終値:
$1.52
開ける：
$1.51
24時間の取引高:
111.29K
Relative Volume:
0.14
時価総額：
$46.95M
収益：
-
当期純損益:
$-42.37M
株価収益率:
-1.4224
EPS:
-1.0686
ネットキャッシュフロー:
$-34.94M
1週間 パフォーマンス:
-1.94%
1か月 パフォーマンス:
-8.43%
6か月 パフォーマンス:
-16.48%
1年 パフォーマンス:
-72.06%
1日の値動き範囲:
$1.5001
$1.59
1週間の範囲:
$1.42
$1.5997
52週間の値動き範囲:
$1.14
$5.96
Skye Bioscience Inc Stock (SKYE) Company Profile
名前
Skye Bioscience Inc
セクター
電話
(858) 410-0266
住所
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
SKYE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
1.55 | 2.39B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.88 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.85 | 209.71M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2426 | 513.93M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.1904 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-06 | ダウングレード | Craig Hallum | Buy → Hold |
| 2025-08-15 | 開始されました | Evercore ISI | Outperform |
| 2025-02-28 | 開始されました | William Blair | Outperform |
| 2024-09-30 | 開始されました | Scotiabank | Sector Outperform |
| 2024-09-10 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-07-09 | 開始されました | Craig Hallum | Buy |
| 2024-05-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-04-12 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Skye Bioscience Inc (SKYE) 最新ニュース
Evaluating Skye Bioscience Inc. with trendline analysis2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
Volatility clustering patterns for Skye Bioscience Inc.Weekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Published on: 2025-11-07 00:39:33 - newser.com
Why Skye Bioscience Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
{固定前缀} What analysts say about Skye Bioscience Inc 09R stockPrice Action Analysis & High Yield Trading Plans - earlytimes.in
Regression analysis insights on Skye Bioscience Inc. performanceJuly 2025 Summary & Verified Technical Signals - newser.com
Is Skye Bioscience Inc. stock supported by innovation pipelineJuly 2025 Reactions & Fast Momentum Entry Tips - fcp.pa.gov.br
How Skye Bioscience Inc. stock performs in weak economyQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Will Skye Bioscience Inc. stock go up soonJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com
Will Skye Bioscience Inc. (09R) stock outperform foreign stocks2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com
Revenue Check: Why Skye Bioscience Inc. (09R) stock is a strong analyst pickInflation Watch & Growth Oriented Trade Recommendations - fcp.pa.gov.br
Skye Bioscience to Announce Third Quarter 2025 Financial Results and Business Update on November 10, 2025 - The Globe and Mail
Will Skye Bioscience Inc. (09R) stock keep raising dividendsQuarterly Trade Report & Risk Adjusted Buy/Sell Alerts - newser.com
What technical models suggest about Skye Bioscience Inc.’s comeback2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-11-05 22:45:14 - newser.com
Intraday pattern recognizer results for Skye Bioscience Inc.Inflation Watch & Expert Approved Trade Ideas - newser.com
Live market analysis of Skye Bioscience Inc.Trade Exit Summary & Weekly High Potential Alerts - newser.com
Can Skye Bioscience Inc. stock maintain growth trajectoryWeekly Trend Recap & Fast Entry Momentum Alerts - newser.com
How Skye Bioscience Inc. stock reacts to inflationary pressures2025 Price Momentum & Low Drawdown Investment Ideas - newser.com
Skye Bioscience (SKYE) Highlights Promising Weight Loss Data at ObesityWeek 2025 - GuruFocus
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain - The Manila Times
Skye Bioscience to Present Late-Breaking Data on Nimacimab at ObesityWeek 2025 - Quiver Quantitative
Skye Bioscience (NASDAQ: SKYE) posts 18.1% vs 49.8% post-treatment regain in Phase 2 - Stock Titan
Skye Bioscience (Nasdaq: SKYE) sets Nov 10 Q3 results call; release after market close - Stock Titan
How to integrate Skye Bioscience Inc. into portfolio analysis toolsBull Run & Weekly High Momentum Picks - newser.com
Published on: 2025-11-05 02:02:08 - newser.com
How Skye Bioscience Inc. stock performs during Fed tightening cycles2025 Macro Impact & Low Drawdown Investment Strategies - newser.com
Published on: 2025-11-04 06:12:12 - newser.com
Published on: 2025-11-04 05:05:28 - newser.com
Will Skye Bioscience Inc. (09R) stock announce a stock split2025 Volatility Report & Safe Entry Momentum Tips - newser.com
Skye Bioscience (SKYE) Price Target Decreased by 41.90% to 8.89 - MSN
Price action breakdown for Skye Bioscience Inc.GDP Growth & Weekly High Conviction Trade Ideas - newser.com
Is Skye Bioscience Inc. (09R) stock a momentum leaderJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Is Skye Bioscience Inc. stock a defensive play in 2025Weekly Risk Report & Growth-Oriented Investment Plans - newser.com
Applying big data sentiment scoring on Skye Bioscience Inc.July 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Skye Bioscience Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Is Skye Bioscience Inc. forming a reversal patternInsider Selling & Weekly Return Optimization Plans - newser.com
Is Skye Bioscience Inc. still worth holding after the dipJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Skye Bioscience Inc (SKYE) 財務データ
収益
当期純利益
現金流量
EPS
Skye Bioscience Inc (SKYE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Schwab Andrew J. | Director |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 22 '25 |
Sale |
3.42 |
170,449 |
582,936 |
57,493 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
| Diep Tuan Tu | Chief Development Officer |
Nov 18 '24 |
Sale |
4.99 |
19,489 |
97,250 |
82,259 |
| Diep Tuan Tu | Chief Development Officer |
Nov 15 '24 |
Sale |
5.55 |
85 |
472 |
101,748 |
| ARSENAULT KAITLYN | Chief Financial Officer |
Nov 18 '24 |
Sale |
4.99 |
43,206 |
215,598 |
166,342 |
| ARSENAULT KAITLYN | Chief Financial Officer |
Nov 15 '24 |
Sale |
5.55 |
190 |
1,054 |
209,548 |
| DHILLON PUNIT | Chief Executive Officer |
Nov 18 '24 |
Sale |
4.99 |
82,546 |
411,905 |
329,823 |
| DHILLON PUNIT | Chief Executive Officer |
Nov 15 '24 |
Sale |
5.55 |
364 |
2,020 |
412,369 |
| Grayson Paul A. | Director |
Nov 18 '24 |
Sale |
4.99 |
86,244 |
430,358 |
259,701 |
4.64%
大文字化:
|
ボリューム (24 時間):